PAXIL CR Bioequivalence Study
Completed · Phase 1
Conditions studied: Depressive Disorder
In brief
This study is to determine if controlled release paroxetine tablets manufactured at two different sites behave similarly in healthy volunteers.
Key facts
- Study ID
- NCT00749359
- Run by
- GlaxoSmithKline
- People needed
- 166
- Starts
- 2008-07-07
- Expected to finish
- 2008-09-16
- Last updated by the study team
- 2017-08-04
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.
Where it is running
- GSK Investigational Site — Buffalo, New York, United States
- GSK Investigational Site — Tacoma, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.